ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,00%
Bitcoin
60.752,85
-0,07%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. AYTU BioPharma Inc (AYTU)

  7. AYTU BioPharma Inc (AYTU) Notícias

AYTU

AYTU BioPharma (AYTU)

AYTU BioPharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AYTU
DataHoraFonteTítuloCódigoCompanhia
10/05/202417:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AYTUAYTU BioPharma Inc
10/05/202417:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AYTUAYTU BioPharma Inc
10/05/202417:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AYTUAYTU BioPharma Inc
14/02/202418:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
13/02/202418:25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AYTUAYTU BioPharma Inc
02/01/202418:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
14/11/202318:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AYTUAYTU BioPharma Inc
12/10/202315:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AYTUAYTU BioPharma Inc
29/09/202317:15Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:AYTUAYTU BioPharma Inc
27/09/202308:28IH Market NewsWednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and moreNASDAQ:AYTUAYTU BioPharma Inc
23/06/202317:55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AYTUAYTU BioPharma Inc
22/06/202317:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AYTUAYTU BioPharma Inc
20/06/202309:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYTUAYTU BioPharma Inc
16/06/202317:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AYTUAYTU BioPharma Inc
12/06/202318:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYTUAYTU BioPharma Inc
12/06/202318:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AYTUAYTU BioPharma Inc
09/06/202309:11Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:AYTUAYTU BioPharma Inc
05/06/202318:25Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:AYTUAYTU BioPharma Inc
26/05/202314:53Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AYTUAYTU BioPharma Inc
11/05/202317:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYTUAYTU BioPharma Inc
01/05/202318:21Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AYTUAYTU BioPharma Inc
15/02/202318:41Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AYTUAYTU BioPharma Inc
16/11/202208:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aytu BioScience (AYTU)NASDAQ:AYTUAYTU BioPharma Inc
14/11/202219:52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AYTUAYTU BioPharma Inc
21/09/202209:00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AYTUAYTU BioPharma Inc
15/08/202217:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AYTUAYTU BioPharma Inc
23/06/202207:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYTUAYTU BioPharma Inc
08/06/202217:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AYTUAYTU BioPharma Inc
28/04/202207:17TipRanksH.C. Wainwright Thinks Aytu BioScience’s Stock is Going to RecoverNASDAQ:AYTUAYTU BioPharma Inc
04/03/202208:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:AYTUAYTU BioPharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AYTU

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
YDUQ3
ESTACIO PART ON
BOV
UNIP6
UNIPAR PNB
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados